Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 493, pseudogene (RNU6-493P)
- Target
- RNU6-493P
- Molecular classification
- Other, pseudogene, non-coding RNA derivative
01
Overview
RNU6-493P is a human pseudogene related to the U6 small nuclear RNA gene. The canonical functional U6 snRNA is a core component of the spliceosome, playing an essential catalytic role in pre-mRNA splicing. U6 snRNA and its functional gene loci are highly conserved and critical for cellular viability. However, RNU6-493P is noncoding and has arisen from duplication and subsequent mutation or sequence drift from the functional gene. Unlike its parental gene, there is no evidence that RNU6-493P encodes a functional RNA or protein, nor is it implicated in biological processes or diseases. Pseudogenes like RNU6-493P typically serve no functional role. Occasionally, pseudogenes can modulate gene expression by acting as decoys for miRNAs or sources of non-coding RNA, but this has not been established for RNU6-493P. As such, it is not a receptor, not a drug target, and not relevant for therapeutic applications.
- Other names
- RNU6-493PRNA, U6 small nuclear 493, pseudogene
02
Mechanism of action
none; not a conventional target for therapeutics.
03
Biological functions
Most pseudogenes have no known coding function. Some, rarely, can regulate parental gene expression or participate in regulatory RNA networks, but for RNU6-493P, there is no experimentally validated function.
04
Disease associations
Other/none
Beyond the preview
Go deeper on RNA, U6 small nuclear 493, pseudogene (RNU6-493P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 493, pseudogene (RNU6-493P).